Status:

UNKNOWN

Role of Sweetness in Glucose Regulation

Lead Sponsor:

University of Illinois at Urbana-Champaign

Collaborating Sponsors:

Washington University School of Medicine

Conditions:

Obesity

Eligibility:

All Genders

21-40 years

Phase:

NA

Brief Summary

Data from several studies show that consuming a diet high in low-calorie sweeteners (LCS), mainly in diet sodas, is linked to the same metabolic disorders as consuming a diet high in added sugars, inc...

Detailed Description

The overall goal of this research is to assess the role of oral and gut sweetness signaling in postprandial glucose metabolism and to determine how acute and chronic low-calorie sweetener (LCS) consum...

Eligibility Criteria

Inclusion

  • All races/ethnicities
  • Habitual (\> 5 diet sodas per week) and non-habitual (≤1 diet soda or 1 packet of LCS per week) LCS consumers
  • 30 ≤ BMI \<40 kg/m2
  • Not severely insulin resistant (HOMA-IR2 \< 2.6)

Exclusion

  • BMI \< 30 and 40\< BMI kg/m2
  • HOMA-IR2\>2.6
  • Irregular LCS consumers (\>1 diet sodas or packets of LCS per week but \<5)
  • Current smokers or quit smoking nicotine cigarettes for less than 6 months ago
  • Pregnant, breastfeeding, menopausal
  • Presence of anemia : \<12g/dl for women and \<13g/dl for men
  • Blood donation in the past 8 weeks
  • Presence of malabsorption syndrome
  • History of bariatric surgery
  • Presence of inflammatory intestinal disease, liver or kidney disease
  • Have diabetes (fasting glucose level \>126mg/dl or plasma glucose level 2h after glucose challenge \>200 mg/dl)
  • Taking any medication that might affect glucose metabolism or the results of our study

Key Trial Info

Start Date :

April 24 2019

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 31 2022

Estimated Enrollment :

80 Patients enrolled

Trial Details

Trial ID

NCT03844230

Start Date

April 24 2019

End Date

December 31 2022

Last Update

April 27 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Illinois at Urbana Champaign

Champaign, Illinois, United States, 61820